Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Publikationen

Suchbegriffe: HYPOCHLOROUS ACID - PHARMACOLOGY , . Treffer: 11

2013

Binder, V; Ljubojevic, S; Haybaeck, J; Holzer, M; El-Gamal, D; Schicho, R; Pieske, B; Heinemann, A; Marsche, G The myeloperoxidase product hypochlorous acid generates irreversible high-density lipoprotein receptor inhibitors.
Arterioscler Thromb Vasc Biol. 2013; 33(5):1020-1027 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2010

Nusshold, C; Kollroser, M; Köfeler, H; Rechberger, G; Reicher, H; Ullen, A; Bernhart, E; Waltl, S; Kratzer, I; Hermetter, A; Hackl, H; Trajanoski, Z; Hrzenjak, A; Malle, E; Sattler, W Hypochlorite modification of sphingomyelin generates chlorinated lipid species that induce apoptosis and proteome alterations in dopaminergic PC12 neurons in vitro.
Free Radic Biol Med. 2010; 48(12): 1588-1600. [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Ullen, A; Fauler, G; Köfeler, H; Waltl, S; Nusshold, C; Bernhart, E; Reicher, H; Leis, HJ; Wintersperger, A; Malle, E; Sattler, W Mouse brain plasmalogens are targets for hypochlorous acid-mediated modification in vitro and in vivo.
Free Radic Biol Med. 2010; 49(11):1655-1665 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2009

Chantepie, S; Malle, E; Sattler, W; Chapman, MJ; Kontush, A Distinct HDL subclasses present similar intrinsic susceptibility to oxidation by HOCl.
Arch Biochem Biophys. 2009; 487(1): 28-35. [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG Google Scholar

 

2007

Marsche, G; Semlitsch, M; Hammer, A; Frank, S; Weigle, B; Demling, N; Schmidt, K; Windischhofer, W; Waeg, G; Sattler, W; Malle, E Hypochlorite-modified albumin colocalizes with RAGE in the artery wall and promotes MCP-1 expression via the RAGE-Erk1/2 MAP-kinase pathway.
FASEB J. 2007; 21(4): 1145-1152. [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

2004

Porubsky, S; Schmid, H; Bonrouhi, M; Kretzler, M; Malle, E; Nelson, PJ; Gröne, HJ Influence of native and hypochlorite-modified low-density lipoprotein on gene expression in human proximal tubular epithelium.
AMER J PATHOL. 2004; 164(6): 2175-2187. [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText Google Scholar

 

2003

Marsche, G; Zimmermann, R; Horiuchi, S; Tandon, NN; Sattler, W; Malle, E Class B scavenger receptors CD36 and SR-BI are receptors for hypochlorite-modified low density lipoprotein.
J Biol Chem. 2003; 278(48):47562-47570 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

2002

Marsche, G; Hammer, A; Oskolkova, O; Kozarsky, KF; Sattler, W; Malle, E Hypochlorite-modified high density lipoprotein, a high affinity ligand to scavenger receptor class B, type I, impairs high density lipoprotein-dependent selective lipid uptake and reverse cholesterol transport.
J Biol Chem. 2002; 277(35):32172-32179 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

1999

Bergt, C; Reicher, H; Malle, E; Sattler, W Hypochlorite modification of high density lipoprotein: effects on cholesterol efflux from J774 macrophages.
FEBS Lett. 1999; 452(3):295-300 [OPEN ACCESS]
Web of Science PubMed Google Scholar

 

1997

Malle, E; Woenckhaus, C; Waeg, G; Esterbauer, H; Gröne, EF; Gröne, HJ Immunological evidence for hypochlorite-modified proteins in human kidney.
Am J Pathol. 1997; 150(2):603-615 [OPEN ACCESS]
Web of Science PubMed PUBMED Central Google Scholar

 

1995

Malle, E; Hazell, L; Stocker, R; Sattler, W; Esterbauer, H; Waeg, G Immunologic detection and measurement of hypochlorite-modified LDL with specific monoclonal antibodies.
Arterioscler Thromb Vasc Biol. 1995; 15(7):982-989 [OPEN ACCESS]
Web of Science PubMed FullText Google Scholar

 

© Meduni Graz Impressum